A Randomized, Double-blind, Placebo-controlled, Crossover Trial of Rizatriptan 10 mg Oral Disintegrating Tablet for Treatment of Acute Attacks of Chronic, Blast-induced, Post-traumatic Headache in U.S. Military Troops.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 20 Aug 2015
At a glance
- Drugs Rizatriptan (Primary)
- Indications Post-traumatic headache
- Focus Therapeutic Use
- 17 Aug 2015 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 09 Nov 2012 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 21 Mar 2012 Planned End Date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.